Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / exact sciences sues rival geneoscopy related to colo mwn benzinga

EXAS - Exact Sciences Sues Rival Geneoscopy Related To Colon Cancer Test Cologuard Patent | Benzinga

Exact Sciences Corporation

Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S. District Court for the District of Delaware.

The lawsuit seeks damages and a court order to stop Geneoscopy from making, using, selling, or offering ColoSense product for sale or otherwise infringing on Exact Sciences' U.S. Patent No. 11,634,781.

Also Read: Full story available on Benzinga.com
Stock Information
Company Name: Exact Sciences Corporation
Stock Symbol: EXAS
Market: NASDAQ
Website: exactsciences.com
Menu
EXAS EXAS Quote EXAS Short EXAS News EXAS Articles EXAS Message Board
Get EXAS Alerts

News, Short Squeeze, Breakout and More Instantly...